Kadmon Small Molecules


Small Molecules

Current therapeutic focus

Immune and Fibrotic Diseases

Structure-Based Drug Design

Kadmon has established a structure-based drug design (SBDD) platform to develop uniquely targeted therapies. Our SBDD platform supports target characterization and facilitates drug development by combining data from x-ray crystallography with molecular modeling and other computational tools. These methods allow for a nuanced understanding of molecular structures and interactions with targets to support development of drug candidates. Combining SBDD efforts with innovative structural biology and medicinal chemistry provides for a rapid and cost-effective lead optimization process.

Metabolomics Platform